The use of Tranexamic Acid in Case of Patient with Intracerebral Hemorrhage After a Coronary Procedure-Case Report.

Medical archives (Sarajevo, Bosnia and Herzegovina) Pub Date : 2024-01-01 DOI:10.5455/medarh.2024.78.317-321

Amra Salkic, Amel Amidzic, Stoja Eric, Nermina Gorana-Polimac, Naida Tiro, Merita Tiric-Campara

{"title":"The use of Tranexamic Acid in Case of Patient with Intracerebral Hemorrhage After a Coronary Procedure-Case Report.","authors":"Amra Salkic, Amel Amidzic, Stoja Eric, Nermina Gorana-Polimac, Naida Tiro, Merita Tiric-Campara","doi":"10.5455/medarh.2024.78.317-321","DOIUrl":null,"url":null,"abstract":"Background: Tranexamic acid can prevent death from bleeding after trauma and postpartum hemorrhage.Objective: The aim of the paper was to assess whether tranexamic acid reduces hematoma expansion and improves outcome in adults with stroke caused by intracerebral hemorrhage.Case presentation: Administration of Tranexamic acid in a patient after a diagnosis of intracerebral hematoma, which occurred after coronary stent implantation. Intracerebral hematoma, or neurological deficit, occurs one day after cardiac surgery in the patient. The case report will present the radiological resolution of the intracerebral hematoma, as well as the improvement of the clinical picture, neurological deficit, in the patient during a one-month follow-up, after the administration of Tranexamic acid.Conclusion: Tranexemic acid is affordable, easy to administer, appears to be safe, and is widely available, so even a modest treatment effect can have an important global impact, and it is necessary to consider its more frequent use, as well as to initiate larger randomized trials.","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 4","pages":"317-321"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11838825/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical archives (Sarajevo, Bosnia and Herzegovina)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/medarh.2024.78.317-321","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Tranexamic acid can prevent death from bleeding after trauma and postpartum hemorrhage.

Objective: The aim of the paper was to assess whether tranexamic acid reduces hematoma expansion and improves outcome in adults with stroke caused by intracerebral hemorrhage.

Case presentation: Administration of Tranexamic acid in a patient after a diagnosis of intracerebral hematoma, which occurred after coronary stent implantation. Intracerebral hematoma, or neurological deficit, occurs one day after cardiac surgery in the patient. The case report will present the radiological resolution of the intracerebral hematoma, as well as the improvement of the clinical picture, neurological deficit, in the patient during a one-month follow-up, after the administration of Tranexamic acid.

Conclusion: Tranexemic acid is affordable, easy to administer, appears to be safe, and is widely available, so even a modest treatment effect can have an important global impact, and it is necessary to consider its more frequent use, as well as to initiate larger randomized trials.

查看原文本刊更多论文

背景：氨甲环酸可预防外伤和产后出血死亡：氨甲环酸可预防创伤后出血和产后出血导致的死亡：本文旨在评估氨甲环酸是否能减少血肿扩大并改善由脑内出血引起的成人中风患者的预后：病例介绍：一名患者在冠状动脉支架植入术后发生脑内血肿，在确诊后给予氨甲环酸治疗。患者在心脏手术后一天出现脑内血肿或神经功能缺损。本病例报告将介绍患者在服用氨甲环酸一个月后，脑内血肿在影像学上消除，临床症状和神经功能缺损也有所改善：氨甲环酸价格低廉、易于使用、似乎很安全，而且可以广泛获得，因此，即使是微小的治疗效果也会对全球产生重要影响，有必要考虑更频繁地使用氨甲环酸，并启动更大规模的随机试验。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Medical archives (Sarajevo, Bosnia and Herzegovina)

自引率

0.00%

发文量